| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/11/2013 | US20130178439 Methods of treating an inflammatory-related disease |
| 07/11/2013 | US20130178425 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 07/11/2013 | US20130178423 Sparc and methods of use thereof |
| 07/11/2013 | US20130178420 Novel glp-1 receptor modulators |
| 07/11/2013 | US20130178419 Method of treating pain by administration of nerve growth factor |
| 07/11/2013 | US20130178418 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 07/11/2013 | US20130178417 Novel nitrogen-containing heteroaryl compounds and methods of use thereof |
| 07/11/2013 | US20130178416 Fusion peptide therapeutic compositions |
| 07/11/2013 | US20130178413 Hcv ns3 protease inhibitors |
| 07/11/2013 | US20130178412 Dihydroxyproply-cysteine peptide and agent containing this peptide |
| 07/11/2013 | US20130178410 Methods for modulating slow myosin |
| 07/11/2013 | US20130177985 DNA Sequence Encoding a Retinoic Acid Regulated Protein |
| 07/11/2013 | US20130177663 Bacteriocins and Novel Bacterial Strains |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177641 Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
| 07/11/2013 | US20130177631 Method and medicament for inhibiting the expression of a given gene |
| 07/11/2013 | US20130177630 Anti-cancer composition and method utilizing 3-bp and liposomal reduced glutathione |
| 07/11/2013 | US20130177628 Compositions and methods for promoting wound healing and tissue regeneration |
| 07/11/2013 | US20130177626 Pharmaceutical compositions comprising cyclosporin |
| 07/11/2013 | US20130177614 Method of use of stabilized non-plant-derived growth factor in skin care |
| 07/11/2013 | US20130177611 Silk-based drug delivery system |
| 07/11/2013 | US20130177607 Nanocell Drug Delivery System |
| 07/11/2013 | US20130177577 Nlrc5 as a target to intervene mhc class 1-mediated immune responses |
| 07/11/2013 | US20130177576 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 07/11/2013 | US20130177569 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 07/11/2013 | US20130177565 Administering anti-placental growth factor antibodies |
| 07/11/2013 | US20130177564 Administering anti-placental growth factor antibodies |
| 07/11/2013 | US20130177558 Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors |
| 07/11/2013 | US20130177549 Treatment of Synucleinopathies |
| 07/11/2013 | US20130177548 Treating neoplasms with neurotoxin |
| 07/11/2013 | US20130177547 Ancestral serine protease coagulation cascade exerts a novel function in early immune defense |
| 07/11/2013 | US20130177541 Modified factor IX polypeptides and uses thereof |
| 07/11/2013 | US20130177536 Enhancement Of Skeletal Muscle Stem Cell Engraftment By Dual Delivery Of VEGF And IGF-1 |
| 07/11/2013 | US20130177532 PEGylation by the Dock and Lock (DNL) Technique |
| 07/11/2013 | US20130177531 Inhibitors of Serine Proteases |
| 07/11/2013 | US20130177530 Antiviral compounds |
| 07/11/2013 | US20130177528 Compositions and methods for inhibiting viral infection |
| 07/11/2013 | US20130177525 Cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 07/11/2013 | US20130177513 Extract of aerial parts of maca rich in polyphenols and composition comprising same |
| 07/11/2013 | US20130177498 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 07/11/2013 | CA2858427A1 Method of treating cancer by administration of low levels of heat shock protein 70 (hsp70) |
| 07/11/2013 | CA2856451A1 Method of treating pain by administration of nerve growth factor |
| 07/10/2013 | EP2613152A2 Sensitizer for an erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same, erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same and method for diagnosing the presence of malignant neoplasms using said erythrocytic diagnostic agent |
| 07/10/2013 | EP2612921A1 Process for production of novel degalactosylated gc globulin |
| 07/10/2013 | EP2612865A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/10/2013 | EP2612678A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor |
| 07/10/2013 | EP2612677A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/10/2013 | EP2612676A1 Use of g-csf dimer in the treatment of neutropenia |
| 07/10/2013 | EP2612675A1 Treatment of development-related disorders |
| 07/10/2013 | EP2612674A1 Freeze-dried recombinant human bone morphogenetic protein-2 preparation |
| 07/10/2013 | EP2611913A2 Bacteriophage lytic enzymes as alternative antimicrobials |
| 07/10/2013 | EP2611902A2 Compositions and methods for modulating emt and uses thereof |
| 07/10/2013 | EP2611827A1 Recombinant t-cell receptor ligands with covalently bound peptides |
| 07/10/2013 | EP2611822A2 Compositions for labeling nerves and methods of use |
| 07/10/2013 | EP2611775A1 Agonists of neurotrophin receptors and their use as medicaments |
| 07/10/2013 | EP2611459A2 Polypeptides derived from -1 antitrypsin and methods of use thereof |
| 07/10/2013 | EP2611458A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
| 07/10/2013 | EP2611457A2 Compositions and methods for treating friedreich's ataxia with interferon gamma |
| 07/10/2013 | EP2611456A2 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 07/10/2013 | EP2611455A1 Material combination for treating inflammatory or infectious diseases |
| 07/10/2013 | EP2611453A1 Antifungal composition |
| 07/10/2013 | EP2611436A1 Combination of hdac inhibitors with thrombocytopenia drugs |
| 07/10/2013 | EP2611419A2 Method for producing a tetranectin-apolipoprotein a-1 lipid particle, the lipid particle itself and its use |
| 07/10/2013 | EP2611418A2 Tetranectin-apolipoprotein a-1, lipid particles containing it and its use |
| 07/10/2013 | EP2611417A2 Method for producing a tetranectin-apolipoprotein a-1 particle, the lipid particle obtained therewith and its use |
| 07/10/2013 | EP2261376B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 07/10/2013 | CN1970571B G-csf analog compositions and methods |
| 07/10/2013 | CN1671425B ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 07/10/2013 | CN103201381A Novel endolysin |
| 07/10/2013 | CN103201285A Modified relaxin polypeptides and their uses |
| 07/10/2013 | CN103201284A Polypeptides derived from IL-2 having agonist activity, for the therapy of cancer and chronic infections |
| 07/10/2013 | CN103201282A Dermatopontin-activating peptides and cosmetic compositions including same |
| 07/10/2013 | CN103200958A Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients |
| 07/10/2013 | CN103200957A Method to increase the growth velocity of human infants |
| 07/10/2013 | CN103200956A Glp-1 receptor agonist compounds having stabilized regions |
| 07/10/2013 | CN103200955A Composition comprising a peptide and an inhibitor of viral neuraminidase |
| 07/10/2013 | CN103200954A Nachra7 agonists and nachra7 antagonists for treating ulcerative colitis (uc) and crohn's disease (cd) |
| 07/10/2013 | CN103200953A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| 07/10/2013 | CN103200952A Treatment of diseases |
| 07/10/2013 | CN103200951A Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition |
| 07/10/2013 | CN103200950A Novel auristatin derivatives and use thereof |
| 07/10/2013 | CN103194517A Chickpea short-peptide mixture and preparation method thereof |
| 07/10/2013 | CN103194515A Method for preparing silkworm pupa protein ACE (angiotensin-I converting enzyme) inhibitory peptide by continuous enzyme membrane reaction, and product and application thereof |
| 07/10/2013 | CN103194478A Soluble recombinant insulin, expression method of insulin derivative and application of insulin |
| 07/10/2013 | CN103193881A Hypoglycemic polypeptide derivative for oral medication and use thereof |
| 07/10/2013 | CN103193878A Mutated hFGF-21 protein mature peptide and mutated hFGF-21 protein mature peptide-polyethylene glycol cross-linking agent and applications thereof |
| 07/10/2013 | CN103193877A Protein and application thereof in preparing antimicrobial product |
| 07/10/2013 | CN103193876A Rana margaretae antioxidation peptide odorranain-H-OM, gene with coding sequence of rana margaretae antioxidation peptide odorranain-H-OM, and application of rana margaretae antioxidation peptide odorranain-H-OM |
| 07/10/2013 | CN103193871A Method for designing novel TALE (transcription activator like effector) according to protein-DNA compound crystal structure |
| 07/10/2013 | CN103193866A Odorranawuchuanensis antioxidant peptide wuchuanin-B2 and gene and application of coding sequence thereof |
| 07/10/2013 | CN103193864A Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 07/10/2013 | CN103191418A Buccal patch for treating dental ulcer by combination of internal and external treatments |
| 07/10/2013 | CN103191417A Long-effect blood-glucose-control medicine-controlled-release system loading insulin aggregate, and preparation method thereof |
| 07/10/2013 | CN103191416A Porcine insulin super-molecular aggregate and preparation method thereof |
| 07/10/2013 | CN103191415A Application of fibroblast growth factor-21 mature peptide in preparing medicine for treating hypertension |
| 07/10/2013 | CN103191414A Fast-absorbed liquid calcium for pet and preparation method thereof |
| 07/10/2013 | CN103191413A Novel purpose of OCT4B protein isomer |
| 07/10/2013 | CN103191412A Degradation of PA200 and acetylation-mediated core histones through proteasome |
| 07/10/2013 | CN103191411A Cyclosporine a and amphiphilic hyaluronic acid derivative composition and preparation method thereof |
| 07/10/2013 | CN103191410A Treatment of T-cell mediated diseases |